Literature DB >> 8971879

Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome.

M G Caletti1, G Gallo, C A Gianantonio.   

Abstract

Renal biopsies from 19 boys and 11 girls, most with moderate or severe forms of hemolytic uremic syndrome (HUS) of the classic diarrhea-associated type, were analyzed as part of their long-term follow-up. Patients were biopsied because of late or persistent proteinuria, hypertension, and prolonged renal failure. The median length of follow-up was 11.2 years (range 0.9-22.0 years). Four histological groups were identified: focal segmental glomerulosclerosis and hyalinosis (FSGSH) (17 patients), diffuse mesangial proliferative glomerulonephritis (DMPGN) (9 patients), diffuse glomerulosclerosis (2 patients), and minimal glomerular changes (2 patients). The median interval between the onset of disease and renal biopsy was significantly shorter in DMPGN than in FSGSH (P < 0.001). The pathological findings may be the expression of two different stages of the same dynamic process: a regular sequence of glomerular lesions consisting of early DMPGN, followed by FSGSH. This lesion would ultimately lead to the final stage of global glomerulosclerosis. At the last examination, only a quarter of the patients had normal renal function. These observations also confirm that prolonged oligoanuria during the acute stage of HUS frequently results in an unfavorable long-term prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8971879     DOI: 10.1007/s004670050189

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

1.  Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2012-04-03       Impact factor: 3.714

2.  Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy.

Authors:  Maria Gracia Caletti; Mabel Missoni; Clarisa Vezzani; María Grignoli; Juan Jose Piantanida; Horacio A Repetto; Ramon Exeni; Stella Maris Rasse
Journal:  Pediatr Nephrol       Date:  2011-04-30       Impact factor: 3.714

3.  Levels of urinary transforming growth factor beta-1 in children with D+ hemolytic uremic syndrome.

Authors:  María Gracia Caletti; Alejandro Balestracci; Adriana Haydeé Roy
Journal:  Pediatr Nephrol       Date:  2010-02-16       Impact factor: 3.714

4.  Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

5.  Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.

Authors:  María Gracia Caletti; Alejandro Balestracci; Mabel Missoni; Clarisa Vezzani
Journal:  Pediatr Nephrol       Date:  2012-12-20       Impact factor: 3.714

Review 6.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

7.  Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome.

Authors:  María Gracia Caletti; Horacio Lejarraga; Diana Kelmansky; Mabel Missoni
Journal:  Pediatr Nephrol       Date:  2004-06-18       Impact factor: 3.714

8.  Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.

Authors:  Robert S Oakes; Justin K Kirkham; Justin K Kirkhamm; Raoul D Nelson; Richard L Siegler
Journal:  Pediatr Nephrol       Date:  2008-05-09       Impact factor: 3.714

9.  Thrombotic Microangiopathy in Inverted Formin 2-Mediated Renal Disease.

Authors:  Rachel C Challis; Troels Ring; Yaobo Xu; Edwin K S Wong; Oliver Flossmann; Ian S D Roberts; Saeed Ahmed; Michael Wetherall; Giedrius Salkus; Vicky Brocklebank; Julian Fester; Lisa Strain; Valerie Wilson; Katrina M Wood; Kevin J Marchbank; Mauro Santibanez-Koref; Timothy H J Goodship; David Kavanagh
Journal:  J Am Soc Nephrol       Date:  2016-12-14       Impact factor: 10.121

Review 10.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.